Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF
Objective: To investigate the effects of combined medication of nifedipine and magnesium sulfate on the blood pressure, pregnancy-associated plasma protein A (PAPP-A), vascular endothelial growth factor (VEGF), nitric oxide (NO), homocysteine (Hcy) and von Willebrand factor (vWF) in gestational hype...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Saudi Journal of Biological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319562X19301445 |
id |
doaj-fd6e0c38c3cc436c8dd3cb7735fe2558 |
---|---|
record_format |
Article |
spelling |
doaj-fd6e0c38c3cc436c8dd3cb7735fe25582020-11-25T00:56:09ZengElsevierSaudi Journal of Biological Sciences1319-562X2019-12-0126820432047Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWFYaohan Wang0Xinyu Zhang1Yaqi Han2Fei Yan3Rui Wu4Department of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaDepartment of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaDepartment of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaDepartment of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaCorresponding author.; Department of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaObjective: To investigate the effects of combined medication of nifedipine and magnesium sulfate on the blood pressure, pregnancy-associated plasma protein A (PAPP-A), vascular endothelial growth factor (VEGF), nitric oxide (NO), homocysteine (Hcy) and von Willebrand factor (vWF) in gestational hypertension patients. Methods: A total of 220 gestational hypertension patients were enrolled as the subjects, and divided into two groups randomly, i.e. the observation group and the control group. In observation group, patients took combined medication of nifedipine and magnesium sulfate, while those in the control group only took magnesium sulfate for treatment. Clinical efficacy, and the changes in blood pressure, PAPP-A, VEGF, NO, Hcy and vWF before and after treatment were compared between two groups. Results: In the observation group and the control group, total effectiveness rates were 92.7% and 70.9%, respectively (p < 0.05). After treatment, we found significant decreases in PAPP-A, VEGF, NO, Hcy and vWF in patients of two groups, with more significant decreases in the observation group (p < 0.05). Incidence rates of the adverse reactions in two groups were 5.5% and 6.4%, respectively, without any statistically significant differences (p > 0.05). In the observation group, patients had fewer complications (p < 0.05). Conclusion: Combined medication of magnesium sulfate and nifedipine can decrease the levels of PAPP-A, VEGF, NO, Hcy and vWF in serum as well as the blood pressure of patients with gestational hypertension, with a reduction in incidence rate of complications and improvement in efficacy. Keywords: Gestational hypertension, Magnesium sulfate, Nifedipine, PAPP-A, VEGF, NO, Hcy, vWFhttp://www.sciencedirect.com/science/article/pii/S1319562X19301445 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yaohan Wang Xinyu Zhang Yaqi Han Fei Yan Rui Wu |
spellingShingle |
Yaohan Wang Xinyu Zhang Yaqi Han Fei Yan Rui Wu Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF Saudi Journal of Biological Sciences |
author_facet |
Yaohan Wang Xinyu Zhang Yaqi Han Fei Yan Rui Wu |
author_sort |
Yaohan Wang |
title |
Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF |
title_short |
Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF |
title_full |
Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF |
title_fullStr |
Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF |
title_full_unstemmed |
Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF |
title_sort |
efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on papp-a, vegf, no, hcy and vwf |
publisher |
Elsevier |
series |
Saudi Journal of Biological Sciences |
issn |
1319-562X |
publishDate |
2019-12-01 |
description |
Objective: To investigate the effects of combined medication of nifedipine and magnesium sulfate on the blood pressure, pregnancy-associated plasma protein A (PAPP-A), vascular endothelial growth factor (VEGF), nitric oxide (NO), homocysteine (Hcy) and von Willebrand factor (vWF) in gestational hypertension patients. Methods: A total of 220 gestational hypertension patients were enrolled as the subjects, and divided into two groups randomly, i.e. the observation group and the control group. In observation group, patients took combined medication of nifedipine and magnesium sulfate, while those in the control group only took magnesium sulfate for treatment. Clinical efficacy, and the changes in blood pressure, PAPP-A, VEGF, NO, Hcy and vWF before and after treatment were compared between two groups. Results: In the observation group and the control group, total effectiveness rates were 92.7% and 70.9%, respectively (p < 0.05). After treatment, we found significant decreases in PAPP-A, VEGF, NO, Hcy and vWF in patients of two groups, with more significant decreases in the observation group (p < 0.05). Incidence rates of the adverse reactions in two groups were 5.5% and 6.4%, respectively, without any statistically significant differences (p > 0.05). In the observation group, patients had fewer complications (p < 0.05). Conclusion: Combined medication of magnesium sulfate and nifedipine can decrease the levels of PAPP-A, VEGF, NO, Hcy and vWF in serum as well as the blood pressure of patients with gestational hypertension, with a reduction in incidence rate of complications and improvement in efficacy. Keywords: Gestational hypertension, Magnesium sulfate, Nifedipine, PAPP-A, VEGF, NO, Hcy, vWF |
url |
http://www.sciencedirect.com/science/article/pii/S1319562X19301445 |
work_keys_str_mv |
AT yaohanwang efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf AT xinyuzhang efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf AT yaqihan efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf AT feiyan efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf AT ruiwu efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf |
_version_ |
1725228098229633024 |